The Future of Long-Term Care in America:
Risks & Opportunities for LTC Pharmacies

Featuring Alan Rosenbloom, President & CEO of the Senior Care Pharmacy Coalition

Nearly 75%  of Americans who need long-term care (LTC) live at home or in the community, not in LTC facilities. Various trends – consumer preferences, the cost of facility-based care, questions about quality in LTC facilities, and expansion of Medicaid-funded home-and-community-based services (HCBS) – have been keeping more people at home and fewer people in facilities. The COVID-19 pandemic has accelerated these trends. While vaccines seem to have brought the pandemic under control, the LTC market remains unsettled and the “new normal” has yet to emerge.

This program considers these accelerating trends and their implications for the future of LTC in America, including the risks and opportunities for LTC pharmacies in the emerging future. The program assesses public policy developments under President Biden and a Congress currently in Democratic hands, and the payment policies that could make or break opportunities for LTC pharmacies in the competition to care for people with LTC needs wherever they live – at home, in the community, or in facilities.   

Special guest Alan Rosenbloom, President & CEO of SCPC, returned to the webinar stage to share his perspective on risks and opportunities for LTC pharmacy, and will help participants:

  • Assess LTC market recovery from COVID-19 pandemic and implications for current and future LTC pharmacy business models
  • Understand public policy initiatives regarding expansion of home and community-based services and drug pricing reform
  • Explore market risks and opportunities arising from LTC market trends and possible policy changes

This live webinar has passed, to watch the recording simply fill out the form to the right for immediate access.

 

Speaker:

Rosenbloom bubble

 

Alan Rosenbloom

President & CEO 

Senior Care Pharmacy Coalition (SCPC)

Alan G. Rosenbloom serves as President & CEO of the Senior Care Pharmacy Coalition (SCPC), the only trade group in Washington dedicated exclusively to the political and public policy interests of long-term care pharmacies. He helped a small group of pharmacies to create the SCPC in October 2014. During his tenure, SCPC assured that legislation to address the opioid crisis recognized the unique characteristics of the LTC patient population and appropriate application to LTC pharmacies, supported market efforts to improve payments and reduce administrative burdens for LTC pharmacies under Medicare Part D and persuaded the FDA to modify regulatory requirements that would have undermined care for patients in LTC facilities. Since founding SCPC in 2014, Alan has more than quintupled both membership and revenues. SCPC represents more than 400 LTC pharmacies caring for more than 850,000 residents in nursing homes and other LTC settings across in all 50 states.

Alan has spent his entire professional career in health care, including stints as President of the Alliance for Quality Nursing Home Care, President and CEO of the Pennsylvania Health Care Association and Acting President, Executive Vice President and Chief Operating Officer of LeadingAge. He began his career as a health care lawyer in Philadelphia, with a particular focus on representing long term providers.

Alan received a Juris Doctor from the University of Pennsylvania, where he served as Associate Editor of The Law Review and also studied public policy at the Wharton School. He received his undergraduate degree from the University of Massachusetts, graduating summa cum laude with a degree in English literature.